NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024

M. Swetter, Susan; B. Johnson, Douglas; R. Albertini, Mark; A. Barker, Christopher; B. Bateni, Sarah; Baumgartner, Joel; Bhatia, Shailender; K. Bichakjian, Christopher; M. Boland, Genevieve; Chandra, Sunandana; Chmielowski, Bartosz; J. DiMaio, Dominick; Dronca, Roxana; C. Fields, Ryan; D. Fleming, Martin; Galan, Anjela; Guild, Samantha; Hyngstrom, John; C. Karakousis, Giorgos; Kendra, Kari; Kiuru, Maija; R. Lange, Julie; M. Lanning, Ryan; F. Logan, Theodore; G. Olson, Daniel; J. Olszanski, Anthony; A. Ott, Patrick; I. Ross, Merrick; D. Rothermel, Luke; K.S. Salama, April; Sharma, Rohit; J. Skitzki, Joseph; Smith, Emily; K. Tsai, Katy; Wuthrick, Evan; Xing, Yan; R. McMillian, Nicole; Espinosa, Sara

doi:10.6004/jnccn.2024.0036

Public

NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024

Published in Journal of the National Comprehensive Cancer Network • Jul 1, 2024

Authors:

Susan M. Swetter

Douglas B. Johnson

Mark R. Albertini

Abstract

The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data ...

Subject

Medicine

Melanoma

Multidisciplinary approach

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!